Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 1

Interventions

pembrolizumab 565Specimen Handling 494Carboplatin 452Magnetic Resonance Spectroscopy 444Cyclophosphamide 421Cisplatin 405Radiotherapy 352Bevacizumab 316Gemcitabine 313Paclitaxel 299Biopsy 290Drug Therapy 284Blood Specimen Collection 249Capecitabine 246fludarabine 241Oxaliplatin 241Nivolumab 235venetoclax 220Injections 213Docetaxel 211Fluorouracil 206Dexamethasone 187Radiosurgery 182Standard of Care 160Rituximab 159Pemetrexed 156Surgical Procedures, Operative 149atezolizumab 146durvalumab 145Leucovorin 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × small molecule inhibitor THX-B × Clear all
NCT05694715 2026-03-17

Combination Therapy in Cancers With Mutations in DNA Repair Genes

University of California, San Francisco

Phase 1 Recruiting
24 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡